Wordt geladen...
Rituximab for Rheumatoid Arthritis
Rituximab is a chimeric monoclonal antibody directed at the CD20 molecule on the surfaces of some but not all B cells. It depletes almost all peripheral B cells, but other niches of B cells are variably depleted, including synovium. Its mechanism of action in rheumatoid arthritis (RA) is only partia...
Bewaard in:
| Gepubliceerd in: | Rheumatol Ther |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer Healthcare
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4883263/ https://ncbi.nlm.nih.gov/pubmed/27747531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-015-0016-9 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|